title: Evidence of an asymmetrical endophenotype in congenital fibrosis of extraocular muscles type 3 resulting from TUBB3 mutations.
abstract: OBJECTIVE
  Orbital magnetic resonance imaging (MRI) was used to investigate the structural basis of motility abnormalities in congenital fibrosis of the extraocular muscles type 3 (CFEOM3), a disorder resulting from missense mutations in TUBB3, which encodes neuron-specific beta-tubulin isotype III.
  
  
  METHODS
  Ophthalmic examinations in 13 volunteers from four CFEOM3 pedigrees and normal control subjects, were correlated with TUBB3 mutation and MRI findings that demonstrated extraocular muscle (EOM) size, location, contractility, and innervation.
  
  
  RESULTS
  Volunteers included clinically affected and clinically unaffected carriers of R262C and D417N TUBB3 amino acid substitutions and one unaffected, mutation-negative family member. Subjects with CFEOM3 frequently had asymmetrical blepharoptosis, limited vertical duction, variable ophthalmoplegia, exotropia, and paradoxical abduction in infraduction. MRI demonstrated variable, asymmetrical levator palpebrae superioris and superior rectus EOM atrophy that correlated with blepharoptosis, deficient supraduction, and small orbital motor nerves. Additional EOMs exhibited variable hypoplasia that correlated with duction deficit, but the superior oblique muscle was spared. Ophthalmoplegia occurred only when the subarachnoid width of CN3 was <1.9 mm. A-pattern exotropia was frequent, correlating with apparent lateral rectus (LR) muscle misinnervation by CN3. Optic nerve (ON) cross sections were subnormal, but rectus pulley locations were normal.
  
  
  CONCLUSIONS
  CFEOM3 caused by TUBB3 R262C and D417N amino acid substitutions features abnormalities of EOM innervation and function that correlate with subarachnoid CN3 hypoplasia, occasional abducens nerve hypoplasia, and subclinical ON hypoplasia that can resemble CFEOM1. Clinical and MRI findings in CFEOM3 are more variable than those in CFEOM1 and are often asymmetrical. Apparent LR innervation by the inferior rectus motor nerve is an overlapping feature of Duane retraction syndrome and CFEOM1. These findings suggest that CFEOM3 is an asymmetrical, variably penetrant, congenital cranial dysinnervation disorder leading to secondary EOM atrophy.
authors.affiliation: Jules Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, CA 90095-7002, USA. jld@ucla.edu
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Demer
authors.forename: Robert A
authors.initials: RA
authors.lastname: Clark
authors.forename: Max A
authors.initials: MA
authors.lastname: Tischfield
authors.forename: Elizabeth C
authors.initials: EC
authors.lastname: Engle
mesh_terms: D000010:Abducens Nerve / Q000002:abnormalities / Q000473:pathology; D000293:Adolescent; D000328:Adult; D019943:Amino Acid Substitution; D005192:Family Health; D005260:Female; D005355:Fibrosis; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009133:Muscular Atrophy / Q000151:congenital / Q000235:genetics / Q000473:pathology; D020125:Mutation, Missense; D009801:Oculomotor Muscles / Q000002:abnormalities* / Q000473:pathology*; D009802:Oculomotor Nerve / Q000002:abnormalities / Q000473:pathology; D015840:Oculomotor Nerve Diseases / Q000151:congenital / Q000235:genetics* / Q000473:pathology*; D009900:Optic Nerve / Q000002:abnormalities / Q000473:pathology; D010375:Pedigree; D010641:Phenotype; D014404:Tubulin / Q000235:genetics*; D014792:Visual Acuity; D055815:Young Adult
chemical_list: C498585:TUBB3 protein, human; D014404:Tubulin
references.citation: J AAPOS. 2002 Dec;6(6):337-47
references.pmid: 12506273
references.citation: Invest Ophthalmol Vis Sci. 1998 Jan;39(1):207-12
references.pmid: 9430565
references.citation: Science. 2008 Aug 8;321(5890):839-43
references.pmid: 18653847
references.citation: Ann Neurol. 1997 Mar;41(3):314-25
references.pmid: 9066352
references.citation: BMC Genet. 2002;3:3
references.pmid: 11882252
references.citation: Am J Hum Genet. 1995 Nov;57(5):1086-94
references.pmid: 7485159
references.citation: Am J Hum Genet. 2002 Nov;71(5):1195-9
references.pmid: 12395297
references.citation: Brain. 2006 Sep;129(Pt 9):2363-74
references.pmid: 16815872
references.citation: Development. 1997 Oct;124(20):4065-75
references.pmid: 9374403
references.citation: Am J Ophthalmol. 2010 Dec;150(6):925-31
references.pmid: 20801423
references.citation: Arch Ophthalmol. 2000 Aug;118(8):1090-7
references.pmid: 10922204
references.citation: Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1601-6
references.pmid: 17389489
references.citation: Nat Genet. 2003 Dec;35(4):318-21
references.pmid: 14595441
references.citation: Neuromuscul Disord. 2003 Sep;13(7-8):573-8
references.pmid: 12921795
references.citation: Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2169-78
references.pmid: 12091413
references.citation: Nat Genet. 1994 May;7(1):69-73
references.pmid: 8075644
references.citation: J AAPOS. 1998 Feb;2(1):17-25
references.pmid: 10532362
references.citation: Acta Radiol. 2002 Jul;43(4):349-53
references.pmid: 12225473
references.citation: Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2218-23
references.pmid: 15223798
references.citation: Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3380-6
references.pmid: 15452039
references.citation: Invest Ophthalmol Vis Sci. 2007 Jan;48(1):194-202
references.pmid: 17197533
references.citation: Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3787-97
references.pmid: 11053278
references.citation: Invest Ophthalmol Vis Sci. 2010 Aug;51(8):3864-73
references.pmid: 20220051
references.citation: Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5057-69
references.pmid: 19494197
references.citation: J AAPOS. 2006 Apr;10(2):135-42
references.pmid: 16678748
references.citation: Cell. 2010 Jan 8;140(1):74-87
references.pmid: 20074521
references.citation: Nat Genet. 2001 Nov;29(3):315-20
references.pmid: 11600883
references.citation: Hum Genet. 2002 May;110(5):510-2
references.pmid: 12073023
references.citation: Am J Hum Genet. 1998 Aug;63(2):517-25
references.pmid: 9683611
references.citation: Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1687-94
references.pmid: 10393037
references.citation: Graefes Arch Clin Exp Ophthalmol. 1997 Sep;235(9):545-50
references.pmid: 9342602
references.citation: Neuron. 1999 Nov;24(3):555-66
references.pmid: 10595509
references.citation: Ophthalmology. 1995 Apr;102(4):607-12
references.pmid: 7724178
references.citation: Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1047-51
references.pmid: 15037567
references.citation: Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5505-11
references.pmid: 18055799
references.citation: Invest Ophthalmol Vis Sci. 2005 Feb;46(2):530-9
references.pmid: 15671279
references.citation: Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3856-65
references.pmid: 12939301